General Information of Drug (ID: DMBQ2TF)

Drug Name
AZD-5438 Drug Info
Synonyms
602306-29-6; AZD5438; AZD-5438; AZD 5438; 4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine; CHEMBL488436; UNII-276Z913G29; MMV676604; 4-[2-METHYL-1-ISOPROPYL-1H-IMIDAZOL-5-YL]-N-[4-(METHYLSULFONYL)PHENYL]-2-PYRIMIDINAMINE; 2-Pyrimidinamine,4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]-N-[4-(methylsulfonyl)phenyl]-; 276Z913G29; 4-(2-methyl-3-propan-2-ylimidazol-4-yl)-N-(4-methylsulfonylphenyl)pyrimidin-2-amine
Cross-matching ID
PubChem CID
16747683
ChEBI ID
CHEMBL488436
CAS Number
CAS 602306-29-6
TTD Drug ID
D06WHY

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Oxidative phosphorylation 2.04 9.63e-3 93/133 (69.92%) PPA1;NDUFA10;NDUFA7;...
Citrate cycle (TCA cycle) 1.99 4.81e-3 30/30 (100%) IDH3A;ACO2;MDH2;...
Rheumatoid arthritis 1.97 3.21e-3 78/93 (83.87%) CCL20;ACP5;HLA-DQA1;...
Fatty acid elongation 1.92 7.22e-3 19/27 (70.37%) HADH;HADHA;ACOT7;...
Ribosome biogenesis in eukaryotes 1.92 7.70e-3 52/108 (48.15%) IMP4;NHP2;GNL3;...
Ribosome 1.90 8.02e-3 113/158 (71.52%) MRPL3;MRPS16;RPL26L1;...
Biosynthesis of unsaturated fatty acids 1.87 1.10e-2 21/27 (77.78%) SCD;ACOT7;ACAA1;...
Fructose and mannose metabolism 1.83 1.08e-2 30/33 (90.91%) SORD;AKR1B10;PFKL;...
Folate biosynthesis 1.78 1.18e-2 23/26 (88.46%) QDPR;AKR1B10;MOCOS;...
Alanine, aspartate and glutamate metabolism 1.78 1.06e-2 27/37 (72.97%) ASS1;CAD;ASRGL1;...
N-Glycan biosynthesis 1.75 1.49e-2 38/50 (76%) ALG8;ALG5;DPAGT1;...
Pentose phosphate pathway 1.74 1.52e-2 25/30 (83.33%) GPI;PGM1;RPIA;...
Purine metabolism 1.73 1.63e-2 102/129 (79.07%) GUCY1A1;AK4;IMPDH2;...
Tryptophan metabolism 1.72 1.72e-2 35/42 (83.33%) HADH;HADHA;ACAT1;...
Lysosome 1.70 2.25e-2 115/128 (89.84%) ACP5;LAPTM4B;ATP6V0B;...
Glutathione metabolism 1.64 3.73e-2 43/57 (75.44%) SRM;GGCT;GGT1;...
Protein export 1.64 3.57e-2 17/23 (73.91%) OXA1L;SRPRB;SPCS1;...
Aminoacyl-tRNA biosynthesis 1.63 3.80e-2 15/66 (22.73%) CARS2;NARS2;GATC;...
One carbon pool by folate 1.63 3.60e-2 15/20 (75%) ATIC;SHMT2;GART;...
Pentose and glucuronate interconversions 1.62 3.66e-2 17/34 (50%) SORD;AKR1B10;UGT2B28;...
Vibrio cholerae infection 1.61 3.48e-2 44/50 (88%) ATP6V0E2;ATP6V0B;ATP6AP1;...
Riboflavin metabolism 1.61 3.37e-2 7/8 (87.5%) ACP5;ACP1;FLAD1;...
Drug metabolism 1.60 3.60e-2 78/151 (51.66%) IMPDH2;NME1;GSTM3;...
Glycolysis / Gluconeogenesis 1.59 4.09e-2 56/67 (83.58%) GPI;PGM1;PFKL;...
Bile secretion 1.59 4.24e-2 68/90 (75.56%) SCARB1;UGT2B28;ADCY3;...
Retinol metabolism 1.57 4.88e-2 41/68 (60.29%) UGT2B28;ALDH1A2;ADH1B;...
Progesterone-mediated oocyte maturation -1.74 3.25e-2 75/100 (75%) IGF1R;CDK1;KRAS;...
Transcriptional misregulation in cancer -1.76 3.45e-2 158/192 (82.29%) TLX3;NR4A3;ETV6;...
Autophagy -1.76 3.52e-2 113/169 (66.86%) RPS6KB1;ATG5;PIK3R3;...
Mitophagy -2.00 2.59e-3 56/68 (82.35%) FOXO3;RRAS;TBC1D17;...
Cell cycle -2.04 0.00e+0 110/124 (88.71%) ABL1;CDKN1C;GADD45G;...
MicroRNAs in cancer -2.10 0.00e+0 146/310 (47.1%) PIK3R3;MARCKS;MMP16;...
FoxO signaling pathway -2.16 0.00e+0 118/131 (90.08%) PIK3R3;ARAF;PLK4;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 0.12uM - 10uM 6H, 24H, 48H
Bone marrow
Chronic myeloid leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
K-562 CVCL_0004 Homo sapiens 0.01uM - 10uM 4H, 24H
Multiple myeloma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
KMS-34 CVCL_1333 Homo sapiens 0.01uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 3H, 6H, 24H, 48H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 3H, 6H, 24H
SK-BR-3 CVCL_0033 Homo sapiens 0.04uM - 10uM 3H, 6H, 24H
Breast carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BT-20 CVCL_0178 Homo sapiens 0.04uM - 10uM 3H, 6H, 24H
Hs 578T CVCL_0332 Homo sapiens 0.04uM - 10uM 3H, 6H, 24H
Normal (Epithelial)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HME1 CVCL_2950 Homo sapiens 0.04uM - 10uM 3H, 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 3H, 6H, 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 0.04uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 6H, 24H, 48H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 0.04uM - 10uM 24H
Lymph node
Burkitt lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BJAB CVCL_5711 Homo sapiens 0.01uM - 2.5uM 24H
Diffuse large B-cell lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HBL-1 CVCL_4213 Homo sapiens 0.01uM - 10uM 4H, 24H
OCI-Ly19 CVCL_8797 Homo sapiens 0.01uM - 10uM 4H, 24H
OCI-Ly3 CVCL_8796 Homo sapiens 0.01uM - 10uM 4H, 24H
TMD8 CVCL_A440 Homo sapiens 0.01uM - 10uM 4H, 24H
Mantle cell lymphoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MINO CVCL_4965 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute B-lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NALM-6 CVCL_0092 Homo sapiens 0.01uM - 2.5uM 24H
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 3.33uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.04uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
LNCaP CVCL_0395 Homo sapiens 0.04uM - 10uM 3H, 24H
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H
SK-MEL-5 CVCL_0527 Homo sapiens 0.01uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.01uM - 10uM 24H